Skip to main content
. Author manuscript; available in PMC: 2018 Mar 14.
Published in final edited form as: Int J Cancer. 2017 May 15;141(4):678–686. doi: 10.1002/ijc.30762

Table 2. Eleven SNPs tested in the validation and combined datasets.

SNP Gene Quality RegulomeDB MAF Discovery Validation Combined
(chromosome) scorea scoreb N (Dead|Alive) MSTd N (Dead|Alive) MST N (Dead|Alive) MST
rs113988120 (2) PAIP2B 0.9 6 0.015
TT 721|118 14.9 505|248 19.7 1226|366 16.3
TA 29|0 9.7 20|5 14.7 49|5 10.3
AA 0|0 - 4|1 13.3 4|1 13.7
rs4780973 (16) LOC101927026 0.99 5 0.31
CC 377|53 12.9 267|109 17.6 644|162 14.7
CT 315|50 15.07 228|119 17.6 543|169 16.2
TT 58|15 21.7 44|27 22.4 102|42 21.93
rs9815265 (2) RAB6B 0.9 3 0.403
TT 279|36 13.4 165|86 19.5 444|122 14.8
TC 362|55 14.6 264|108 19.1 626|163 15.6
CC 109|27 22 126|65 18.7 235|92 18.8
rs6438217 (3) ZBTB20 1 6 0.164
TT 492|93 15.7 367|173 19.5 859|266 16.6
TC 234|22 13.9 166|80 19.5 400|102 14.8
CC 24|3 10.5 19|5 13.3 43|8 12.4
rs12638565 (3) ROBO1 0.93 No data 0.233
CC 448|72 16 310|143 20.7 758|215 17.3
CT 264|43 13.1 180|87 17.6 444|130 14.4
TT 38|3 9.5 60|27 19.7 98|30 13.7
rs4568126 (3) B4GALT4 0.99 6 0.421
CC 266|35 13.4 120|59 18.4 386|94 14.5
CA 361|53 14.3 249|123 18.8 610|176 15.4
AA 123|30 18.6 187|77 20 310|107 18.9
rs12186112 (3) UPK1B 0.99 6 0.405
AA 286|40 12.9 199|82 19.5 485|122 14.7
AC 342|52 14.8 250|122 19.5 592|174 16.3
CC 122|26 18.3 93|49 18.1 215|75 17.4
rs13060627 (3) LRRC15 1 V264I 0.264
CC 423|58 13.1 304|144 19 727|202 14.7
CT 281|46 15.7 207|95 20.3 488|141 17.2
TT 46|14 20 37|18 15 83|32 18.4
rs923936 (3) LRRC15 1 L133L 0.234
GG 458|62 13.5 29|13 18.5 487|75 13.8
GA 254|43 15.2 203|92 19.5 457|135 16.9
AA 38|13 20.7 313|150 19 351|163 17.6
rs13173842 (5) SLIT3 0.79 4 0.321
CC 363|59 15.1 246|116 18.9 609|175 16
CT 305|52 14.8 237|112 20.1 542|164 16.3
TT 82|7 12.4 60|27 17.3 142|34 13.7
rs10926274 (1) NA 0.72 4 0.483
AA 189|22 12.4 127|50 19.1 316|72 14.2
AG 393|57 14.8 262|131 19.9 655|188 15.8
GG 168|39 17 162|72 18.4 330|111 17
a

Imputation quality score.

b

Minor allele frequency based on imputation of the GWAS data.

c

Score 3a, 4,5, and 6 indicate TF binding + any motif + DNase peak, TF binding + DNase peak, TF binding or DNase peak, or other, respectively.

d

Median survival time in months.